Developing countries have their own characteristic problems with infection control.
Infection control in developing countries differs markedly from that in the developed countries. It is important that both local and international authorities take these differences into account when formulating policies for use in developing countries. This review examines these issues and sets out some suggestions for improvements. The advantages of involving local experts in the development of such policies are emphasized.
Raza
M W
MW
Department of Microbiology, Freeman Hospital, Freeman Road, Newcastle upon Tyne N7 7DQ, UK. mraza7@hotmail.com
Kazi
B M
BM
Mustafa
M
M
Gould
F K
FK
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D003428:Cross Infection / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control; D003625:Data Collection; D019049:Developed Countries; D003906:Developing Countries; D004363:Drug Utilization; D005240:Feasibility Studies; D006266:Health Education; D006291:Health Policy; D006292:Health Priorities; D006801:Humans; D017053:Infection Control / Q000458:organization & administration*; D008485:Medical Audit; D020380:Needs Assessment / Q000458:organization & administration*; D011159:Population Surveillance; D011785:Quality Assurance, Health Care; D012959:Socioeconomic Factors; D018581:Technology Transfer
D000900:Anti-Bacterial Agents